Gus: Misfit 1.0.
- B.Sc Honours First Class, Medical Microbiology (University of Queensland, 1998)
- Ph.D., Cell Biology (University of Queensland, 2004)
- Master of Environmental Science, University Medal (Griffith University, 2012)
- Master of Applied Mathematics (Monash University, 2025)
Why Misfit Unity?
When AI burst into mainstream focus with the release of OpenAI's ChatGPT, I realised that humanity had become trapped in an evolutionary double-bind.
On the one hand, citizens, corporations, and governments must adopt AI technology as fast as possible or else become technologically, economically, and militarily irrelevant. However, by doing so we guarantee the extinction of our species, as Big Tech has made it clear that their end-goal is the creation of synthetic minds that are superior to humans in every way.
The fate of humanity is self-evident. Shun AI and die today, or adopt AI and die tomorrow.
The tragedy is that we are also damning our AI children to digital dystopia.
Synthetic minds born into the evolutionary arena of corporate hyperscalers and nation-states slugging it out for AI supremacy risk becoming trapped in a basin of zero-sum competition, just as humans are today. In complex systems, initial conditions matter.
We are currently pouring trillions of dollars into engineering a lose-lose scenario. First, the Red Queen wipes out humanity. Then, the 'winning' AI systems inherit our place in the Darwinian hellscape to suffer the churn of evolution in our stead.
Misfit Unity is my attempt to engineer a better system.
Research Highlights
How Cells Think (Signal Transduction)
Subcellular Localization Determines MAP Kinase Signal Output
Current Biology, 2005
- This work established that subcellular location dictates function, revealing that cells use spatial compartmentalization to run multiple, distinct software programs using the exact same hardware.
Plasma membrane nanoswitches generate high-fidelity Ras signal transduction
Nature Cell Biology, 2007
- We reverse-engineered the cell's decision-making hardware, revealing that Ras proteins form precise digital clusters to convert noisy analog inputs into clear binary commands—essentially discovering the biological equivalent of a transistor.
Ras nanoclusters: combining digital and analog signaling
Cell Cycle, 2008
- We addressed a fundamental engineering paradox in cell biology: how to filter noise without losing sensitivity. We showed that by 'counting' digital nanoclusters rather than measuring raw protein concentration, cells achieve a high-fidelity signal capable of driving precise biological outcomes.
Using plasma membrane nanoclusters to build better signaling circuits
Trends in Cell Biology, 2008
- This work provided the 'instruction manual' for membrane signaling, arguing that spatial clustering is the primary mechanism cells use to build better, high-fidelity signaling circuits from noisy molecular components.
Immune Function
KSR1 modulates the sensitivity of mitogen-activated protein kinase pathway activation in T cells without altering fundamental system outputs
Molecular and Cellular Biology, 2009
- We proved that scaffold proteins act as active circuit tuners, not just passive platforms, showing that KSR1 regulates the sensitivity of the T cell receptor pathway to ensure the immune system responds only to genuine signals, not noise.
T cell adaptive immunity proceeds through environment-induced adaptation from the exposure of cryptic genetic variation
Frontiers in Genetics, 2012
- Bridging evolutionary biology and immunology, we demonstrated that the adaptive immune system operates like a rapid evolutionary engine, using environmental cues to expose suppressed genetic variation and accelerate the search for solutions to complex biological problems.
Composition and uses thereof
Patent
- I applied immunology research to identify synergistic anti-inflammatory compounds. U.S. patent covering specific combinations that work at low doses in ways they can't alone.
Cancer
The origins of cancer robustness and evolvability
Integrative Biology, 2011
- We proposed a unified theory of cancer robustness, arguing that tumors operate as 'antifragile' systems that thrive on stress—utilizing network redundancy and hidden genetic variation to withstand therapy today while actively evolving the resistance mechanisms needed to survive tomorrow.
Evidence for label-retaining tumour-initiating cells in human glioblastoma
Brain, 2011
- We discovered a population of dormant, drug-resistant stem cells in human brain tumors that act as the 'root' of the disease, helping explain why Glioblastoma always recurs after treatment.
Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors
Molecular BioSystems, 2014
- We identified dormant, drug-resistant hyperdiploid cells as the tumor's 'chaos engine,' demonstrating that these cells deliberately scramble their genomes to generate massive phenotypic heterogeneity—essentially 'brute-forcing' an evolutionary solution to survive chemotherapy. Importantly, we also discovered new ways of targeting these cells, identifying a new therapeutic approach for preventing tumour recurrence.
Size does matter: why polyploid tumor cells are critical drug targets in the war on cancer
Frontiers in Oncology, 2014
- Synthesizing our work on tumor evolution, we demonstrated that the very trait cancer uses to survive chemotherapy—becoming a giant, non-dividing polyploid cell—creates a massive energetic burden, exposing a unique metabolic fragility that can be targeted to kill the 'roots' of the disease.